| Trial ID: | L0892 |
| Source ID: | IRCT2014090210826N14
|
| Associated Drug: |
Purslane seeds
|
| Title: |
Effect of Purslane seeds on liver enzymes, lipid profile and FBS in patients with nonalcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non alcoholic fatty liver. <br>Nonalcoholic fatty liver disease (NAFLD)
|
| Interventions: |
Intervention 1: Intervention group: using low caloric diet (kilo caloric/ body weight) - 500.15% protein, 55% carbohydrate, 30% fat.also they use10 gr purslane seed daily for 8 weeks. Intervention 2: Control group: using low caloric diet (kilo caloric/ bo
|
| Outcome Measures: |
Liver supersonic graphy. Timepoint: before & after intervention. Method of measurement: radiologic picture.;AST. Timepoint: before and after intervention. Method of measurement: blood sample.;ALT. Timepoint: before and after intervention. Method of measurement: blood sample.;Alkalin phosphat. Timepoint: before and after intervention. Method of measurement: blood sample.Triglycerid. Timepoint: before and after intervention. Method of measurement: mgr/dl, blood sample.;Insulin. Timepoint: before and after intervention. Method of measurement: blood sample.;Malon di aldehid. Timepoint: before and after intervention. Method of measurement: blood sample.;DPPH. Timepoint: before and after intervention. Method of measurement: blood sample.;Weight. Timepoint: before avd after intervention. Method of measurement: digital scale.;Hieght. Timepoint: before avd after intervention. Method of measurement: stadiometer,m.;Waist circumfrence. Timepoint: before avd after intervention. Method of measurement: meter,cm.;FBS. Timepoint: before and after intervention. Method of measurement: mg/dl.;Total cholestrol. Timepoint: before and after intervention. Method of measurement: mgr/dl, blood sample.;LDL. Timepoint: before and after intervention. Method of measurement: mgr/dl, blood sample.;HDL. Timepoint: before and after intervention. Method of measurement: mgr/dl, blood sample.
|
| Sponsor/Collaborators: |
Research deputy, Shahid Sadoughi University of Medical Sciences
|
| Gender: |
All
|
| Age: |
25 years75 years
|
| Phases: |
Phase 3
|
| Enrollment: |
60
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: computerized genererated random number table.
|
| Start Date: |
26/09/2014
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
14 January 2019
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/11246
|
